用CytoSorb和oXiris进行双重血液净化,用于治疗复发性败血症休克:一个病例报告
Bartłomiej Włochacz1, Andrzej Rybak1, Agnieszka Próchnicka1
1Department of Anesthesiology and Intensive Care, Legionowo Hospital, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
The American journal of case reports
|January 24, 2025
概括
这份案例报告表明,将CytoSorb血吸和oXiris连续置换疗法结合起来,可能会改善复发性败血症休克患者的治疗结果,减少炎症标志物并有助于恢复.
科学领域:
- 关键护理医学 关键护理医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- 败血症的管理通常需要辅助体外血液净化.
- CytoSorb是一种用于减少炎症性细胞因子的医疗器械.
- oXiris是一款用于连续血过吸附的高吸附膜过器.
研究的目的:
- 用CytoSorb和oXiris治疗的复发性败血症休克病例描述.
- 评估这些辅助疗法的潜在好处在一个危急病患者.
主要方法:
- 一名67岁的男性患者患有复发性败血性休克,接受了抗生素,血管压缩剂,异型药物,机械呼吸和连续置换疗法 (CRRT) 的治疗.
- 辅助疗法包括使用oXiris过器的CRRT和CytoSorb血吸.
- 患者的病情和炎症标志物 (前素,CRP) 被监测.
主要成果:
- 在使用oXiris过器和CytoSorb吸附剂启动CRRT后,观察到快速的临床改善.
- 观察到,前素和C反应蛋白 (CRP) 水平显著下降.
- 患者在治疗开始后5天内从重症监护室 (ICU) 出院.
结论:
- 虽然缺乏大型临床试验数据,但这一案例支持使用CytoSorb和oXiris作为毒症潜在的辅助治疗方法.
- 这些设备可以通过减少炎症负担来帮助管理严重的败血症和败血症休克.
相关概念视频
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...